about
Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosisLiver fibrosis: mechanisms of immune-mediated liver injuryEDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against CancerIncreased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and CirrhosisUncoupling between inflammatory and fibrotic responses to silica: evidence from MyD88 knockout miceMechanisms of hepatic fibrogenesisLiver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.Alterations of serum protein N-glycosylation in two mouse models of chronic liver disease are hepatocyte and not B cell driven.B cells limit repair after ischemic acute kidney injury.Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial.Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.Association of age-dependent liver injury and fibrosis with immune cell populations.Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury.Role for hedgehog pathway in regulating growth and function of invariant NKT cells.Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells.Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease.T cell-derived lymphotoxin regulates liver regenerationOroxylin A accelerates liver regeneration in CCl₄-induced acute liver injury miceTranscriptional heterogeneity of IgM+ cells in rainbow trout (Oncorhynchus mykiss) tissues.Inhibition of the CXCL12/CXCR4 chemokine axis with AMD3100, a CXCR4 small molecule inhibitor, worsens murine hepatic injury.Hepatic inflammation and fibrosis: functional links and key pathways.Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis.Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression.Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population.Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity.Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.The contribution of B cells to renal interstitial inflammationDonor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliteransAcute Liver Injury Is Independent of B Cells or Immunoglobulin M.Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice.Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells.Management of patients with difficult autoimmune hepatitis.Hepatoprotective effects of baicalein against CCl₄-induced acute liver injury in mice.B cell response is required for granuloma formation in the early infection of Schistosoma japonicum.Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.Cellular and molecular mechanisms of liver tolerance.Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.Ischemia-reperfusion and immediate T cell responsesDual role of CCR2 in the constitution and the resolution of liver fibrosis in mice.
P2860
Q27021577-76498E8F-BD47-471A-9616-815732CE07FAQ27027766-A43FA429-F6E8-4649-9AA5-5528ED4235ABQ27340196-2A51F939-6345-4F6A-AE10-4CC657C554DDQ27485310-09C52DE5-6AD4-4870-BBD1-59222C5599ABQ28390731-B84D4CCA-EF18-47BC-A9C1-39A37AC169C5Q29619336-7E7C47CE-7DC6-4F44-B6FC-9DCF1E7EC4E0Q30374500-C9604403-443D-40EC-B23C-7D7298EF5593Q30997802-7C02CC71-F359-41E2-9C4B-0393B9E1D83DQ33748553-50FF0E73-8C19-4568-8DBF-9FD2DA35EEBCQ33755829-1013DB09-C184-4EA2-89EB-B76287E62B6EQ33923359-D022E8D1-F390-4BDB-BA5A-21360ECFAD0AQ34070116-DD78BEDA-F393-4D7D-B7E6-9F89B966820BQ34118689-1F834698-329A-4988-AC0A-C704C7122F6DQ34238670-BD18988B-541C-4E27-BB41-8BD89077265FQ34247943-26EEA04E-8DFE-4B92-ADF1-1A41109457C3Q34341357-E5C66CB6-5AF0-4627-A84B-34CCDA21C33FQ34629103-7016AFF2-3ADE-46A8-B3E2-6204876F71BCQ34698244-622A8E2F-35F2-41A6-A232-56978A1EC2FCQ34950079-8C3FE0ED-56A6-4A7F-AB64-DAFB2C607D6CQ35064296-647BBBDB-1D71-4F04-B764-4362C84B9556Q35132609-67AFCF12-22C0-4B5D-BF23-4436D03AE81FQ35213917-067366C2-D39C-4466-A23E-B6DBD7BB5B6AQ35226097-B4ABD7E6-6B03-4C4D-AA28-94F949B02337Q35631723-34F66488-DEAE-48F9-927C-A17E1ED66CC8Q35633193-1F095EEC-50FB-44E8-B0D4-1E9D71FAF41FQ35637517-4BE413BF-4E4B-45E4-AE73-06F7E96FD6CAQ35649446-E140CE69-7650-4A30-B960-09A30CC81945Q35750182-E3C2504D-DFF0-4272-B80D-3196FBE26020Q35776453-C3AAA141-1F26-4E9B-BC3D-00A7123DAF7EQ35788209-0D2BC1E2-22FF-4548-A121-C7CE4AA131B2Q35855163-92A82CEB-C84F-4771-BACE-F6E684E031A5Q36053809-155FEDBF-3C9D-453D-8D22-1D87E61D1AF8Q36379083-788835DD-686B-4B42-BB3E-0B8979E69131Q36450452-5DE50179-C379-4B7A-AC45-9A0B085D2951Q36471300-E87131F5-E8E3-4945-91CC-7E39876BE08AQ36491894-E6C84E16-CD6F-4BEB-9795-D743B289E49FQ36593734-A5A2D2F2-FAAD-46D4-8683-549B77A06B45Q36865097-F7FB2AD5-E977-424A-A5ED-A6C3F4D220A4Q36973884-42083D07-18CD-45F5-A645-FD4893395464Q37164206-76EA88A0-5521-4869-B6FF-2A71D4BD8ED4
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Attenuated liver fibrosis in the absence of B cells
@en
Attenuated liver fibrosis in the absence of B cells
@nl
type
label
Attenuated liver fibrosis in the absence of B cells
@en
Attenuated liver fibrosis in the absence of B cells
@nl
prefLabel
Attenuated liver fibrosis in the absence of B cells
@en
Attenuated liver fibrosis in the absence of B cells
@nl
P2093
P2860
P356
P1476
Attenuated liver fibrosis in the absence of B cells
@en
P2093
Aldo Amatucci
Alexander Ibraghimov
Gerard R Majeau
Ian Brenner
Mark J Shlomchik
Paula S Hochman
Sophia Kogan
Stefano Casola
Tatiana I Novobrantseva
P2860
P304
P356
10.1172/JCI24798
P407
P577
2005-11-01T00:00:00Z